The Current Ratio as of November 2024 (TTM) for Nascent Biotech, Inc. (NBIO) is 0.31

According to Nascent Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.31. This represents a change of -59.58% compared to the average of 0.76 of the last 4 quarters.

Nascent Biotech, Inc. (NBIO) Historical Current Ratio (quarterly & annually)

How has NBIO Current Ratio performed in the past?

The mean historical Current Ratio of Nascent Biotech, Inc. over the last ten years is 0.34. The current 0.31 Current Ratio has changed 8.92% with respect to the historical average. Over the past ten years (40 quarters), NBIO's Current Ratio was at its highest in in the September 2017 quarter at 4.19. The Current Ratio was at its lowest in in the June 2020 quarter at 0.00.

Nascent Biotech, Inc. (NBIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nascent Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nascent Biotech, Inc. (NBIO) Average Current Ratio

How has NBIO Current Ratio performed in the past?

The current Current Ratio of Nascent Biotech, Inc. (NBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nascent Biotech, Inc. (NBIO) Current Ratio vs. Peers

How is NBIO’s Current Ratio compared to its peers?

Nascent Biotech, Inc.’s Current Ratio is greater than ProtoKinetix, Incorporated (0.08), greater than RespireRx Pharmaceuticals Inc. (0.01), less than Silo Pharma, Inc. (7.91), greater than VG Life Sciences Inc. (0), less than Mymetics Corporation (0), greater than Neutra Corp. (0.00), greater than Protagenic Therapeutics, Inc. (0.00), less than Sino Biopharmaceutical Limited (0), less than ZIVO Bioscience, Inc. (1.80), less than Cyteir Therapeutics, Inc. (1.15), greater than Eledon Pharmaceuticals, Inc. (0.17), less than Innovation Pharmaceuticals Inc. (21.89), less than Allena Pharmaceuticals, Inc. (6.53), less than YS Biopharma Co., Ltd. (0), greater than null (0.19), less than null (2.11), less than null (0.94),

Build a custom stock screener for Nascent Biotech, Inc. (NBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nascent Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nascent Biotech, Inc. (NBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nascent Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.